These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 8868205)
21. Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: a randomized trial. Collins ED; Kleber HD; Whittington RA; Heitler NE JAMA; 2005 Aug; 294(8):903-13. PubMed ID: 16118380 [TBL] [Abstract][Full Text] [Related]
22. Fluoxetine versus placebo in depressed alcoholic cocaine abusers. Cornelius JR; Salloum IM; Thase ME; Haskett RF; Daley DC; Jones-Barlock A; Upsher C; Perel JM Psychopharmacol Bull; 1998; 34(1):117-21. PubMed ID: 9564208 [TBL] [Abstract][Full Text] [Related]
23. Analysis of monoamine oxidase A (MAO-A) promoter polymorphism in male heroin-dependent subjects: behavioural and personality correlates. Gerra G; Garofano L; Bosari S; Pellegrini C; Zaimovic A; Moi G; Bussandri M; Moi A; Brambilla F; Mameli A; Pizzamiglio M; Donnini C J Neural Transm (Vienna); 2004 May; 111(5):611-21. PubMed ID: 15088154 [TBL] [Abstract][Full Text] [Related]
24. Does naltrexone affect craving in abstinent opioid-dependent patients? Dijkstra BA; De Jong CA; Bluschke SM; Krabbe PF; van der Staak CP Addict Biol; 2007 Jun; 12(2):176-82. PubMed ID: 17508990 [TBL] [Abstract][Full Text] [Related]
25. Naltrexone implant for the treatment of polydrug dependence: a randomized controlled trial. Tiihonen J; Krupitsky E; Verbitskaya E; Blokhina E; Mamontova O; Föhr J; Tuomola P; Kuoppasalmi K; Kiviniemi V; Zwartau E Am J Psychiatry; 2012 May; 169(5):531-6. PubMed ID: 22764364 [TBL] [Abstract][Full Text] [Related]
26. Gender differences in hostility of opioid-dependent outpatients: role in early treatment termination. Petry NM; Bickel WK Drug Alcohol Depend; 2000 Feb; 58(1-2):27-33. PubMed ID: 10669052 [TBL] [Abstract][Full Text] [Related]
27. Serotonin function in detoxified heroin abusers: prolactin and cortisol responses to fenfluramine challenge. Gerra G; Fertonani G; Tagliavini P; Zaimovic A; Delsignore R; Maestri D; Avanzini P; Caccavari R; Brambilla F Psychiatry Res; 1995 Sep; 58(2):153-60. PubMed ID: 8570767 [TBL] [Abstract][Full Text] [Related]
28. A comparison of antagonist-precipitated withdrawal under anesthesia to standard inpatient withdrawal as a precursor to maintenance naltrexone treatment in heroin users: outcomes at 6 and 12 months. McGregor C; Ali R; White JM; Thomas P; Gowing L Drug Alcohol Depend; 2002 Sep; 68(1):5-14. PubMed ID: 12167548 [TBL] [Abstract][Full Text] [Related]
29. Neuroendocrine correlates of antisocial personality disorder in abstinent heroin-dependent subjects. Gerra G; Zaimovic A; Moi G; Bussandri M; Delsignore R; Caccavari R; Brambilla F Addict Biol; 2003 Mar; 8(1):23-32. PubMed ID: 12745412 [TBL] [Abstract][Full Text] [Related]
30. Hostility is associated with a heightened prolactin response to meta-chlorophenylpiperazine in abstinent cocaine addicts. Handelsman L; Kahn RS; Sturiano C; Rinaldi PJ; Gabriel S; Schmeidler JP; Bernstein DP; Siever L; Cooper TB Psychiatry Res; 1998 Jul; 80(1):1-12. PubMed ID: 9727959 [TBL] [Abstract][Full Text] [Related]
31. New-onset mania and psychosis following heroin detoxification and naltrexone maintenance. Sullivan MA; Nunes EV Am J Addict; 2005; 14(5):486-7. PubMed ID: 16257886 [No Abstract] [Full Text] [Related]
32. A randomized control trial of group counseling in a naltrexone treatment program. Tucker T; Ritter A; Maher C; Jackson H J Subst Abuse Treat; 2004 Dec; 27(4):277-88. PubMed ID: 15610829 [TBL] [Abstract][Full Text] [Related]
33. [Depression and aggression. A control group study on the aggression hypothesis in depressive disorders based on the Buss-Durkee Questionnaire]. Wolfersdorf M; Kiefer A Psychiatr Prax; 1998 Sep; 25(5):240-5. PubMed ID: 9816604 [TBL] [Abstract][Full Text] [Related]
34. Naltrexone in patients with bipolar disorder and alcohol dependence. Brown ES; Beard L; Dobbs L; Rush AJ Depress Anxiety; 2006; 23(8):492-5. PubMed ID: 16841344 [TBL] [Abstract][Full Text] [Related]
35. Long-lasting effects of (+/-)3,4-methylenedioxymethamphetamine (ecstasy) on serotonin system function in humans. Gerra G; Zaimovic A; Ferri M; Zambelli U; Timpano M; Neri E; Marzocchi GF; Delsignore R; Brambilla F Biol Psychiatry; 2000 Jan; 47(2):127-36. PubMed ID: 10664829 [TBL] [Abstract][Full Text] [Related]
36. The efficacy of naltrexone in preventing reabuse of heroin after detoxification. Shufman EN; Porat S; Witztum E; Gandacu D; Bar-Hamburger R; Ginath Y Biol Psychiatry; 1994 Jun; 35(12):935-45. PubMed ID: 8080893 [TBL] [Abstract][Full Text] [Related]
37. Trait aggression and hostility in recovered alcoholics. Ziherl S; Cebasek Travnik Z; Kores Plesnicar B; Tomori M; Zalar B Eur Addict Res; 2007; 13(2):89-93. PubMed ID: 17356280 [TBL] [Abstract][Full Text] [Related]
38. Relationship of personality traits and drug of choice by cocaine addicts and heroin addicts. Gerra G; Bertacca S; Zaimovic A; Pirani M; Branchi B; Ferri M Subst Use Misuse; 2008; 43(3-4):317-30. PubMed ID: 18365934 [TBL] [Abstract][Full Text] [Related]
39. Naltrexone: report of lack of hepatotoxicity in acute viral hepatitis, with a review of the literature. Brewer C; Wong VS Addict Biol; 2004 Mar; 9(1):81-7. PubMed ID: 15203443 [TBL] [Abstract][Full Text] [Related]
40. Effects of incentives for naltrexone adherence on opiate abstinence in heroin-dependent adults. Jarvis BP; Holtyn AF; DeFulio A; Dunn KE; Everly JJ; Leoutsakos JS; Umbricht A; Fingerhood M; Bigelow GE; Silverman K Addiction; 2017 May; 112(5):830-837. PubMed ID: 27936293 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]